🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Arizona › Phoenix

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Phoenix, AZ

6 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #67, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Ap rekriteFaz 3
  • Cancer Center at Saint Joseph's, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06524544

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Ap rekriteFaz 2/3
  • Research Site, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07815665

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic Comprehensive Cancer Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07169734

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.